Suven Pharmaceuticals: September ’22 Results Update
Moneylife Digital Team 13 December 2022
In Q2FY22-23, Suven Pharmaceuticals’s (Suven’s) sales declined by 8% y-o-y (year-on-year) on account of a higher base, due to COVID-19-related sales which was nil in the September quarter....
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback